Xin Xie

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Chinese Academy of Sciences, Spreadtrum Communications (Shanghai) Co., Ltd., Semiconductor Manufacturing International (Beijing) Corporation. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Xie. Retrieved from https://idiyas.com/inventor/xin-xie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 84.6

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

7 out of 3,371

Chinese Academy of Sciences

patents

4 out of 284

Spreadtrum Communications (Shanghai) Co., Ltd.

patents

1 out of 951

Semiconductor Manufacturing International (Beijing) Corporation

patents

4. 1 out of 1,757

Semiconductor Manufacturing International (Shanghai) Corporation

patents

5. 1 out of 2

Shanghai Puyi Chemical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2011-2021

Loading Chart...

Areas of Expertise:

Pentacyclic Triterpene

GPR84 Antagonist

Pharmaceutical Composition

Cyclic Amine Compounds

Wireless Network Control

Hexahydrodibenzoquinolizine

Thiazole Compounds

Aggregation Frame Control

Clear Channel Assessment

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11192916 - Pentacyclic triterpene compound and preparation method therefor, and pharmaceutical composition and use thereof (2021-12-07),

2. 11098071 - GPR84 receptor antagonist and use thereof (2021-08-24),

3. 10177246 - Semiconductor structure and fabrication method thereof (2019-01-08),

4. 10167299 - 1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof (2019-01-01),

5. 9887802 - Method and apparatus for controlling transmission rate of physical layer (2018-02-06),

6. 9806858 - Method and apparatus for controlling length of aggregation frame in wireless network (2017-10-31),

7. 9737517 - Pharmaceutical use of hexahydro-dibenzo[a,g]quinolizine compounds (2017-08-22),

8. 9713169 - Method and apparatus for controlling startup of request to send/clear to send mechanism (2017-07-18),

9. 9693363 - Method and apparatus for controlling clear channel assessment threshold (2017-06-27),

10. 9643941 - 2,2'-tandem dithiazole compound, preparation method therefor, and use thereof (2017-05-09),

11. 9359372 - Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof (2016-06-07),

12. 9216962 - Thiazole compounds, methods for preparation and use thereof (2015-12-22),

13. 8039492 - Substituted cyclic compound, its preparation process and its medical use (2011-10-18),

Title: Inventor Xin Xie - Revolutionizing Technology in Shanghai

Introduction: Xin Xie is a pioneering inventor based in Shanghai, China, known for her groundbreaking contributions to the field of technology.

Latest Patents: Xin Xie holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing her innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Xin Xie has worked with leading tech companies in Shanghai, driving innovation and pushing the boundaries of what is possible in the tech industry.

Collaborations: Xin Xie has collaborated with top research institutions and universities in China, fostering a culture of innovation and knowledge-sharing to propel the tech sector forward.

Conclusion: Xin Xie's dedication to innovation and her relentless pursuit of technological advancement make her a standout figure in the inventor community, inspiring the next generation of inventors to dream big and create change.

Profile summary based on public USPTO records.